BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29417354)

  • 1. Clonal dynamics in a case of acute monoblastic leukemia that later developed myeloproliferative neoplasm.
    Sato S; Itonaga H; Taguchi M; Sawayama Y; Imanishi D; Tsushima H; Hata T; Moriuchi Y; Mishima H; Kinoshita A; Yoshiura KI; Miyazaki Y
    Int J Hematol; 2018 Aug; 108(2):213-217. PubMed ID: 29417354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.
    Rothenberg-Thurley M; Amler S; Goerlich D; Köhnke T; Konstandin NP; Schneider S; Sauerland MC; Herold T; Hubmann M; Ksienzyk B; Zellmeier E; Bohlander SK; Subklewe M; Faldum A; Hiddemann W; Braess J; Spiekermann K; Metzeler KH
    Leukemia; 2018 Jul; 32(7):1598-1608. PubMed ID: 29472724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias.
    Abdel-Wahab O; Manshouri T; Patel J; Harris K; Yao J; Hedvat C; Heguy A; Bueso-Ramos C; Kantarjian H; Levine RL; Verstovsek S
    Cancer Res; 2010 Jan; 70(2):447-52. PubMed ID: 20068184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of nonleukemic cellular subcompartments reconstructs clonal evolution of acute myeloid leukemia and identifies therapy-resistant preleukemic clones.
    Saeed BR; Manta L; Raffel S; Pyl PT; Buss EC; Wang W; Eckstein V; Jauch A; Trumpp A; Huber W; Ho AD; Lutz C
    Int J Cancer; 2021 Jun; 148(11):2825-2838. PubMed ID: 33411954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation.
    Cocciardi S; Dolnik A; Kapp-Schwoerer S; Rücker FG; Lux S; Blätte TJ; Skambraks S; Krönke J; Heidel FH; Schnöder TM; Corbacioglu A; Gaidzik VI; Paschka P; Teleanu V; Göhring G; Thol F; Heuser M; Ganser A; Weber D; Sträng E; Kestler HA; Döhner H; Bullinger L; Döhner K
    Nat Commun; 2019 May; 10(1):2031. PubMed ID: 31048683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.
    Jan M; Snyder TM; Corces-Zimmerman MR; Vyas P; Weissman IL; Quake SR; Majeti R
    Sci Transl Med; 2012 Aug; 4(149):149ra118. PubMed ID: 22932223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal evolution of pre-leukemic hematopoietic stem cells precedes human acute myeloid leukemia.
    Majeti R
    Best Pract Res Clin Haematol; 2014; 27(3-4):229-34. PubMed ID: 25455271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia.
    Shuai W; Zuo Z; Li N; Garces S; Jelloul FZ; Ok CY; Li S; Xu J; You MJ; Wang W; Rehder C; Jabbour EJ; Patel KP; Medeiros LJ; Yin CC
    Cancer; 2023 Mar; 129(6):878-889. PubMed ID: 36583229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms.
    Palomo L; Meggendorfer M; Hutter S; Twardziok S; Ademà V; Fuhrmann I; Fuster-Tormo F; Xicoy B; Zamora L; Acha P; Kerr CM; Kern W; Maciejewski JP; Solé F; Haferlach C; Haferlach T
    Blood; 2020 Oct; 136(16):1851-1862. PubMed ID: 32573691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of mutations and clonal evolution patterns in a cohort of patients with cytogenetically normal acute myeloid leukemia.
    Mat Yusoff Y; Ahid F; Abu Seman Z; Abdullah J; Kamaluddin NR; Esa E; Zakaria Z
    Mol Cytogenet; 2021 Sep; 14(1):45. PubMed ID: 34560908
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Ogasawara T; Kawauchi K; Ono T; Marshall S; Shide K; Shimoda K; Mori N; Sakura H
    Leuk Res Rep; 2020; 13():100194. PubMed ID: 32042586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
    Hou HA; Lin YC; Kuo YY; Chou WC; Lin CC; Liu CY; Chen CY; Lin LI; Tseng MH; Huang CF; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
    Ann Hematol; 2015 Feb; 94(2):211-21. PubMed ID: 25241285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?
    Yilmaz M; Wang F; Loghavi S; Bueso-Ramos C; Gumbs C; Little L; Song X; Zhang J; Kadia T; Borthakur G; Jabbour E; Pemmaraju N; Short N; Garcia-Manero G; Estrov Z; Kantarjian H; Futreal A; Takahashi K; Ravandi F
    Blood Cancer J; 2019 Jan; 9(2):7. PubMed ID: 30651532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated Phase of Myeloproliferative Neoplasms.
    Shahin OA; Chifotides HT; Bose P; Masarova L; Verstovsek S
    Acta Haematol; 2021; 144(5):484-499. PubMed ID: 33882481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation in TET2 in myeloid cancers.
    Delhommeau F; Dupont S; Della Valle V; James C; Trannoy S; Massé A; Kosmider O; Le Couedic JP; Robert F; Alberdi A; Lécluse Y; Plo I; Dreyfus FJ; Marzac C; Casadevall N; Lacombe C; Romana SP; Dessen P; Soulier J; Viguié F; Fontenay M; Vainchenker W; Bernard OA
    N Engl J Med; 2009 May; 360(22):2289-301. PubMed ID: 19474426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clonal evolution of myeloid malignancies].
    Kon A
    Rinsho Ketsueki; 2020; 61(9):1120-1129. PubMed ID: 33162507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute myeloid leukemia stem cells from genomic and immunological perspectives].
    Goyama S
    Rinsho Ketsueki; 2020; 61(9):1130-1137. PubMed ID: 33162508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protracted Clonal Trajectory of a
    Langabeer SE; Haslam K; Smyth MA; Quinn J; Murphy PT
    Case Rep Hematol; 2018; 2018():8713020. PubMed ID: 29854499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.
    Beer PA; Delhommeau F; LeCouédic JP; Dawson MA; Chen E; Bareford D; Kusec R; McMullin MF; Harrison CN; Vannucchi AM; Vainchenker W; Green AR
    Blood; 2010 Apr; 115(14):2891-900. PubMed ID: 20008300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome.
    Zhang SJ; Rampal R; Manshouri T; Patel J; Mensah N; Kayserian A; Hricik T; Heguy A; Hedvat C; Gönen M; Kantarjian H; Levine RL; Abdel-Wahab O; Verstovsek S
    Blood; 2012 May; 119(19):4480-5. PubMed ID: 22431577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.